Compare EVO & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EVO | NX |
|---|---|---|
| Founded | 1993 | 1927 |
| Country | Germany | United States |
| Employees | 4553 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 852.1M |
| IPO Year | N/A | 2008 |
| Metric | EVO | NX |
|---|---|---|
| Price | $3.07 | $18.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $28.00 |
| AVG Volume (30 Days) | 47.1K | ★ 286.5K |
| Earning Date | 04-08-2026 | 06-04-2026 |
| Dividend Yield | N/A | ★ 1.64% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,837,641,000.00 |
| Revenue This Year | $1.37 | $4.26 |
| Revenue Next Year | $10.05 | $1.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 43.81 |
| 52 Week Low | $2.31 | $11.04 |
| 52 Week High | $4.42 | $22.90 |
| Indicator | EVO | NX |
|---|---|---|
| Relative Strength Index (RSI) | 56.03 | 49.34 |
| Support Level | $2.88 | $18.30 |
| Resistance Level | $3.75 | $20.24 |
| Average True Range (ATR) | 0.07 | 0.74 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 89.58 | 61.78 |
Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.
Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.